The precision of the BD Onclarity™ HPV Assay may help you improve your patients’ care experience.1
The BD Onclarity™ HPV Assay is designed to reduce the number of false-positive and false-negative results by using gene-specific PCR primers and an internal control so you can be confident in the results that you get.1
The BD Onclarity™ HPV Assay provides:
- Excellent detection of HPV infections with multiple genotypes thanks to genotype-specific primers and probes (instead of consensus primers).1,2
- Minimal risk of false-positive results due to no cross-reactivity with low-risk HPV genotypes.1,3,4
- Minimal risk of false-negative results by:
- Similar sensitivity and specificity on self-collected and clinician-collected samples, as opposed to signal amplification-based and mRNA-based HPV assays that seem to have a lower sensitivity on self-collected samples.7-10
BD Onclarity™ HPV Assay offers a reliable DNA PCR-based assay design providing high sensitivity and specificity for results that you can trust.1